INTRAVENOUS LEIOMYOMATOSIS OF THE UTERUS WITH EARLY PREGNANCY

Intravenous leiomyomatosis is a rare uterineneoplasm, histologically characterized by nodularmasses of benign smooth muscle growing withinthe uterine and pelvic veins. The entity has ty-pical gross and microscopic features. A case of intravenous leiomyomatosisassociated with uterine leiomyoma, adenomyosisand early pregnancy was reported. The condi-tion was recognized during surgery for uterinefibroids. This is, to our knowledge, the thirdcase of intravenOUs leiomyomatosis associatedwith pregnancy so far reported.     

COMPUTERIZED TOMOGRAPHY IN TUBERCULOUSMENINGITIS

This paper reports computerized tomography(CT) findings in 21 cases of tuberculous meningitis,normal in 5 and abnormal in 16. ' The cases withabnormal CT findings were hydrocephalus, tuber-culoma, exudation in basal cisterns, brain edema andcerebral infarction. The incidence of hydrocephalusincreased with the duration and severity of illness.The Iocations of tuberculomas corresponded withpatients' clinical pictures. The study also indicatedthat patients wih normal or slighly changed scanshad good prognosis, but patients with severe hydrocephalus and exudation m basal cisterns had poorprognosis in spite of active medical treatment. CThas been proved valuable in diagnosis and treatmentof tuberculous meningitis.     

Hepatoprotective effects of diethylcarbamazine in acute liver damage induced by carbon tetrachloride in rats

This research was carried out to determine a potential role of leukotrienes in the acute hepatotoxicity induced by CC14 in rats. An inhibitor of leukotrienes biosynthesis, diethylcarbamazine (DEC, 25 and 50 mg ·kg-1 ip) exerted hepatoprotective effects, decreasing the activity of alanine aminotransfer-ase in serum and the concentration of liver triglycerides. DEC reduced histological damage of liver evidenced by electron microscopy. The hepatoprotective effects of DEC were dose-dependent. The results favor the role of leukotrienes in CC14 hepatotoxicity.     

PRENATAL DIAGNOSIS OF CONJOINED TWINSWI''TH REAL-TIME ULTRASOUNDA CASE REPORT

Conjoined twins case is a rare abnormality.The most common type of union is thoracopaguswhich is found in 75To of the cases. Conjoinedtwins have a sex predilection with 75Vo beingFcmale.i A case of conjoined twins was diagnoscdwith real-time ultrasonic scanner (Linear arraymodel, transducer 3.5 mHz) at the 21st week ofpcstation. Final.ly. it was shown late.r by po.slmor-tem examination after delivery that concurrentmalformation in head, hearts and aorta were pre-sent as previously seen on the ultrasonic imagcs.     

APPLICATION OF ACUPOINT-INJECTION THERAPY TO PAIN SYNDROME: CLINICAL ANALYSIS OF 250 CASES

In this paper,250 cases of headache,shoulder pain,lumbago and leg pain weretreated with 20％Angelicae Sinensis mixed with Vitamine B_(12) point-injection therapy.The total effective rate was 95.2％and in which the cure rate was 53.6％.Authors have found a close correlation between the effectiveness and the duration of disease.     

A群多糖脑膜炎菌苗最适免疫剂量的研究

近些年来对Ａ群多糖脑膜炎菌苗最适免疫剂量进行了一系列现场流行病学及血清学效果的对比研究。首先肯定了我国生产的菌苗与法国Ｍｅｒｉｅｕｘ研究所生产的苗苗在人体接种后观察一年内具有同等杀菌抗体反应。以后在严格对比下观察了国内生产的多糖菌苗接种３０μｇ及５０μｇ一年内的血清杀菌抗体反应。结果完全相同；而全身反应则３０μｇ为５０μｇ剂量的五分之一。在我国８０年代流脑流行地区内确证了３０μｇ免后人群保护率为９９％与国外５０μｇ的保护率（９７．２％）相似。国内连续三年在流行地区内对比观察了３０μｇ、与５０μｇ的流行病学预防效果，其人群保护率相似．与国外（Ｒｅｉｎｇｏｌｄ）．的报告亦相似。最后结论是本菌苗的最适免疫剂量为３０μｇ．不但其预防效果与５０μｇ相同，而且菌苗反应轻微，经济效益高，有利于在发展中国家推广使用。     

PHA RMA COKINETICS OF CUPRIC－BIS（SALICYLALDEHYDE－2－FURA NTHIOCA RBOXY－HYDRAZONATE） DICHLORIDE（CSFTCH） IN RABBITS

ＰＨＡＲＭＡＣＯＫＩＮＥＴＩＣＳＯＦＣＵＰＲＩＣ－ＢＩＳ（ＳＡＬＩＣＹＬＡＬＤＥＨＹＤＥ－２－ＦＵＲＡＮＴＨＩＯＣＡＲＢＯＸＹ－ＨＹＤＲＡＺＯＮＡＴＥ）ＤＩＣＨＬＯＲＩＤＥ（ＣＳＦＴＣＨ）ＩＮＲＡＢＢＩＴＳ￥ＧａｏＹｕｎｓｈｅｎｇ；ＺｈｕＹｕｙｕｎ（...     

ISCHEMIC PAPILLOPATHY AND CONTRACEPTIVES

In January and again in April 1985, a 30-year old woman received 150 mg injections of Depo-Provera for contraception. 3 days after the 2nd injection, she experienced blurred vision in both eyes and was diagnosed as having bilateral papilledema. Her vision improved after treatment with vitamin B1 and other drugs. But optic atrophy of the right eye and papilledema of the left eye remained. In July 1985, after an injection with Depo-Provera, her vision again worsened. The woman received no more Depo-Provera after this time. In early 1987, she was referred to Beijing's Tong Ren Hospital, where she was diagnosed as having bilateral ischemic papillopathy and optic atrophy. There have been few documented cases in medical literature of ocular complications related to use of contraceptives. In 1981, Petursson et al. reported a case of macula edema resulting from oral contraceptives. In animal studies, oral contraceptives have been linked to papilledema and retinal vein obstruction. The case reported here is the 1st to link use of Depo- Provera with ocular complications.     

DIMETHYL-1-CURINE DIMETHOCHLORIDE - AN ALTERNA- TIVE FOR d-TUBOCURARINE CHLORIDE

Dimethyll-curine dimethochloride was obtained by methylating the l-curine which was isolated from plants belonging to Genesia Cyclea widely distributed in Hainan Island, South China. It is a non-depolariz- ing post neuromuscular junctional blocker acting upon N2 receptor. Its chemical structural formula, physical properties, pharmacological actions and acute or chronic toxicities have been thoroughly studied. Its biological activities varied a great deal in different experimental animals but their clinical potency is uniform. Its activity is 51.8% as those of d-tubocura rine. Clinically, 1,449 cases, male and female, aged and young, were studied. Among them 422 were employed for endotracheal intubation, 468 for muscu Iar relaxation and 559 for both. Operation varied, including intracraneal, intra-abdominal and open heart surgery. Different kinds of anesthetics and adjuvants were used in association. I.V. dosage of 0.4-0.5 mg/kg or more was enough for intubation while 0.2-0.3 mg/kg for relaxation. Average duration of action was 30-40 minutes, but could be prolonged after heavy doses. Side effects were limited only to mild hypotension and temporal face freshness, while cardiovascular disturbances were very insig- nificant.     

未破裂脑动脉瘤的治疗选择

未破裂脑动脉瘤的处理存在争议。由于其自然史尚未完全明确,因此最佳的治疗策略也不清楚。目前对未破裂脑动脉瘤处理的共识包括观察、显微手术夹闭和血管内治疗。用于随访已知未破裂脑动脉瘤的方法学也有争议,可能取决于经治医生的偏好。大多数动脉瘤由神经外科医师和介入神经放射科医师处理,但未破裂动脉瘤通常是由神经科医师在对患者进行其他神经系统疾病的筛查时首先发现的。因此,关于何时对患者进行筛查和如何对未破裂动脉瘤采取最佳处理的知识将对其日常医疗实践有直接的影响。未破裂动脉瘤经常导致包括缺血事件、癫和头痛在内的其他神经系统症状,这些症状可能促进更积极的干预治疗。由于缺乏设计完善真正基于人群的研究或随机试验,因此目前的最佳处理必须以现有文献和每例患者当时的具体情况为根据。